Literature DB >> 28705755

Isolation and Whole-genome Sequence Analysis of the Imipenem Heteroresistant Acinetobacter baumannii Clinical Isolate HRAB-85.

Puyuan Li1, Yong Huang2, Lan Yu3, Yannan Liu1, Wenkai Niu1, Dayang Zou4, Huiying Liu1, Jing Zheng1, Xiuyun Yin5, Jing Yuan6, Xin Yuan7, Changqing Bai8.   

Abstract

OBJECTIVES: Heteroresistance is a phenomenon in which there are various responses to antibiotics from bacterial cells within the same population. Here, we isolated and characterised an imipenem heteroresistant Acinetobacter baumannii strain (HRAB-85).
METHODS: The genome of strain HRAB-85 was completely sequenced and analysed to understand its antibiotic resistance mechanisms. Population analysis and multilocus sequence typing were performed.
RESULTS: Subpopulations grew in the presence of imipenem at concentrations of up to 64μg/mL, and the strain was found to belong to ST208. The total length of strain HRAB-85 was 4,098,585bp with a GC content of 39.98%. The genome harboured at least four insertion sequences: the common ISAba1, ISAba22, ISAba24, and newly reported ISAba26. Additionally, 19 antibiotic-resistance genes against eight classes of antimicrobial agents were found, and 11 genomic islands (GIs) were identified. Among them, GI3, GI10, and GI11 contained many ISs and antibiotic-resistance determinants.
CONCLUSIONS: The existence of imipenem heteroresistant phenotypes in A. baumannii was substantiated in this hospital, and imipenem pressure, which could induce imipenem-heteroresistant subpopulations, may select for highly resistant strains. The complete genome sequencing and bioinformatics analysis of HRAB-85 could improve our understanding of the epidemiology and resistance mechanisms of carbapenem-heteroresistant A. baumannii.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Acinetobacter baumannii; carbapenem; genomic island; heteroresistance; insertion sequence

Mesh:

Substances:

Year:  2017        PMID: 28705755     DOI: 10.1016/j.ijid.2017.07.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.

Authors:  Sarah E Anderson; Edgar X Sherman; David S Weiss; Philip N Rather
Journal:  mSphere       Date:  2018-08-15       Impact factor: 4.389

2.  Comparative genomic analysis and multi-drug resistance differences of Acinetobacter baumannii in Chongqing, China.

Authors:  Ling Pu; Zuoyi Jian; Fen Pan; Yang Geng; Miao He; Pu Liao
Journal:  Infect Drug Resist       Date:  2019-09-11       Impact factor: 4.003

3.  Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains.

Authors:  Feiyang Zhang; Qin Li; Jiawei Bai; Manlin Ding; Xiangjin Yan; Guangxi Wang; Baoli Zhu; Yingshun Zhou
Journal:  Front Microbiol       Date:  2021-12-02       Impact factor: 5.640

Review 4.  Acinetobacter baumannii Antibiotic Resistance Mechanisms.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Zoi Dorothea Pana; Athanasios Tragiannidis
Journal:  Pathogens       Date:  2021-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.